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ABSTRACT 
Background: Evaluation of cell viability is one of the most important steps of the 
quality control process of cells used therapeutically. The aim of this study was to 
evaluate the long-term cell viability profile of human dental pulp stem cells (hDPSC) 
subcultures (beyond 10 passages) to determine which of these passages are suitable for 
clinical use, and to identify the cell death processes that may occur in the last passages. 
Methods: Four different cell viability assays were combined to determine the average 
cell viability levels (ACVL) at each cell passage: Trypan blue exclusion test, WST-1, 
LIVE/DEAD and electron probe X-ray microanalysis (EPXMA). Apoptosis was 
assessed by TUNEL assay and caspase 4 and BCL7C western blotting, and cell 
proliferation was analyzed by WST-1 and PCNA protein detection. Results: hDPSC 
showed high ACVL from passages P11 to P14, with adequate cytoplasmic and 
mitochondrial functionality at these subcultures. A non-significant trend to decreased 
cell proliferation was found from P16 to P20. EPXMA and TUNEL analyses suggest 
that a preapoptotic process could be activated from P15 to P20 (p<0.001), with a 
correlation with caspase 4 and BCL7C expression. Conclusions: hDPSC corresponding 
to passages P11 to P14 show adequate cell function, proliferation and viability. 
Therefore, these cells could be considered as potentially useful for clinical applications. 
Keywords: Cell viability, Dental pulp, Mesenchymal stem cells, Electron-probe X-
ray microanalysis. 
 
INTRODUCTION 
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Human dental pulp stem cells (hDPSC) have only become known from 2,000 on, and 
these cells have been deeply studied and characterized since then (1). hDPSC are 
considered to be the most feasible and promising stem cells derived from human teeth 
due to their biological properties, easy obtaining and for being present almost during the 
whole lifespan in the dental pulp of permanent human teeth. hDPSC are clonogenic and 
highly proliferative, even more than bone marrow mesenchymal stem cells (2). 
Furthermore, hDPSC are very similar to other adult mesenchymal stem cells regarding 
the positive expression of mesenchymal undifferentiation markers and the negative 
expression of CD45 (3-4). hDPSC have high differentiation potential, showing great 
capabilities to differentiate to chondrogenic, osteogenic, adipogenic, but also neurogenic 
and even epithelial lineages (1, 5-8). Because of this, these cells are globally considered 
as mesenchymal stem cells (MSC) (2, 4, 6, 9-12). As other stem cells, hDPSC are 
increasingly used in regenerative medicine, especially for the development of biological 
substitutes (artificial tissues) by Tissue Engineering (TE) (5, 8, 13-19). 
In this regard, it is necessary to ensure the proliferative and regenerative potential of 
cells used in regenerative medicine and TE protocols in order to guarantee the success 
of these protocols (20-24). Therefore, evaluation of cell viability is one of the most 
important goals of the quality control process of cells used for the generation of 
artificial tissues. Moreover, understanding the specific cell death mechanisms that may 
occur during sequential cell culturing would contribute to a better selection of the most 
appropriate cell sources. 
Several methods have been used to the date to evaluate cell viability, ranging from 
commonly used methods based on the analysis of the integrity of the cell membrane 
using vital exclusion dyes such as trypan blue (25-26), to other assays focused on the 
study of cell metabolism such as AM calcein staining or WST-1 methods (27). One of 
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the most interesting methods designed to evaluate cell viability is electron probe X-ray 
microanalysis (EPXMA), which allows the accurate determination of cell viability and 
the identification of the mechanisms underlying cell death by quantification of the ionic 
elements that play a key role in cell viability. This method has been extensively used for 
the study of cell viability of different cell types, including hDPSC (28-30). 
Adult stem cells cultured in laboratory for several passages tend to show a typical 3-
steps cell viability profile as previously reported (20, 22-23): (i) an initial adaptation to 
ex vivo cell culture conditions associated to a slight decrease of cell viability; (ii) an 
increasing  period, when cell viability rises and cells reach the top cell viability levels. 
Cells at this moment are recommended for use in regenerative medicine; and (iii) a 
decreasing phase, when cells tend to lose viability and cell death is present. It is not 
recommended to use cells at this period. 
hDPSC viability was recently studied during the first 10 cell subcultures (23) by using 
an array of cell viability assays. However, hDPSC reached the top cell viability at the 
end of the study (passage 9). Thus, it is necessary to go further on this type of research 
and to analyze long-term hDPSC subcultures (beyond 10 passages) to determine if these 
passages are also suitable for clinical use, and because it is important to identify those 
subcultures in which cells undergo active cell death and the mechanisms underlying this 
process. Once the cell viability profile has been evaluated, researchers will be able to 
choose hDPSC subcultures with optimal cell viability and proliferation, as well as to 
discard low-viability subcultures for therapeutic use. 
The aim of this study was to evaluate the cell viability profile of long-term hDPSC 
subcultures (from 11th to 20th passages) to determine the putative usefulness of these 
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cells and to identify the stage when hDPSC tend to lose cell viability. In addition, the 
mechanisms involved in cell death and its early indicators will be analyzed. 
 
MATERIAL AND METHODS 
Samples and hDPSC Cultures 
Four human dental pulps were obtained from young adult teeth (from 18 to 30 years). 
All these teeth were third molars without dental or periodontal pathology extracted by 
dental prescription at the School of Dentistry of the University of Granada. All teeth 
presented a fully developed root stage (closed apex stage). 
Once extracted, teeth were stored at 4ºC in Dulbecco’s modified Eagle’s medium 
(Sigma-Aldrich Company, Steimheim, Germany) supplemented with 600 U/mL 
penicillin, 0.6 mg/mL streptomycin and 1.5 µg/mL anfotericin B (Sigma-Aldrich) and 
immediately processed at the Tissue Engineering Laboratory at the School of Medicine 
of the University of Granada. 
Dental pulps were extracted and digested as previously described (2). The medium used 
for hDPSC culture was Dulbecco’s modified Eagle’s medium (Sigma-Aldrich) 
supplemented with 10% fetal bovine serum (Sigma-Aldrich; Cat: F9665; Lot: 
062M3398, St Louis, MO, USA) and 1% antibiotic/antimycotic solution (Sigma-
Aldrich). Medium was changed every 3 days and cells were subcultured at 
subconfluence using a 0.5 g/L trypsin and 0.2 g/L ethylendediaminetetraacetic (EDTA) 
solution (Sigma-Aldrich) at 37ºC for 4 min. Cells were kept in culture until the 20th 
passage and analyzed from passage 11 (P11) to passage 20 (P20). 
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Trypan Blue vital dye exclusion assay 
To determine the number of cells and their viability using trypan blue, 20 µL of 
trypsinized and resuspended cells were mixed with 20 µL of 0.4% solution of trypan 
blue dye (Sigma-Aldrich) for 1 minute. Cells were immediately counted using a 
Neubauer microchamber (Brand GmbH, Wertheim, Germany) with a light microscope. 
All counts were done using 4 technical duplicates of each sample. Means and standard 
deviations were calculated for each subculture. 
 
WST-1 metabolic proliferation and cell viability assay 
To determine the mitochondrial metabolic activity and cell proliferation of hDPSC, the 
WST-1 method was used as previously described (22-23). Briefly, 10,000 cells were 
cultured in 96-well plates (Iwaki, Japan). After subsequent subculture for 48 hours, cells 
were rinsed with phosphate buffered saline (PBS) and 10% WST-1 reagent solution 
(Roche Diagnostics, Indianapolis, IN, USA) was added for 4 hours at 37º C. Then, each 
sample was analyzed using a UVM 340 plate reader (Asys, Cambridge, UK). As 
negative controls, selected cultured wells were previously treated with 2% Triton X-100 
(Probus, Barcelona, Spain). All counts were done using 4 technical duplicates of each 
sample. 
 
LIVE/DEAD® cell viability assay 
Simultaneous evaluation of cytoplasmic function and membrane integrity was carried 
out by LIVE/DEAD® Viability/cytotoxicity kit for mammalian cells (Invitrogen, Oregon, 
USA) assay. This assay provides information about the functional status of cell by 
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detecting the cytoplasmic sterase activity. The kit consist on two fluorescent dyes: AM 
calcein, which pass across the cell membrane. Once hydrolyzed by cytoplasmic sterase 
(live cells), calcein show fluorescence in 515 nm emission wavelength. On the other 
hand, ethidium homodymer only show fluorescence (617 nm emission wavelength) 
after binding to DNA. Thus, red fluorescence only appears in cells whose cell 
membrane is disrupted (dead cells). LIVE/DEAD® cell viability assay was performed 
using chamber slides (LabTek II, Nunc, Rochester, NY, USA). Briefly, 20,000 cells 
were seeded on each well and cultured for 48 h. Then, cells were rinsed twice with PBS, 
and cell viability was assessed using LIVE/DEAD® kit according to the manufacturer’s 
protocol as previously described (22-23). Cell counts were done using 6 technical 
duplicates of each sample. 
 
Electron probe X-ray microanalysis (EPXMA) 
For X-ray microanalysis, confluent hDPSC were subcultured using trypsin-EDTA on 
plated gold grids covered with a thin layer of Pioloform (polyvinyl butyral) (Ted Pella, 
Inc., Redding, CA) and sterilized overnight under UV light. Cells were seeded at a 
density of 5,000 cells per grid and cultured in DMEM supplemented with 10% serum 
and antibiotics. Then, grids containing the cells were washed with deionized water at 4º 
C, plunge-frozen, freeze-dried, carbon-coated and analyzed using a scanning electron 
microscope with a EDAX microanalytical as previously described (20, 22-23). For each 
cell, the intracellular ionic concentration of Na, Mg, P, S, Cl, K and Ca, as well as the 
K/Na ratio were determined. 50 cells were analyzed per cell passage. 
 
Average Cell Viability Levels (ACVL) 
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In order to calculate average cell viability levels (ACVLs) for each cell passage (22-23), 
the raw cell viability values as determined by trypan blue, WST-1, LIVE/DEAD® and 
K/Na index were first normalized to z-scores (mean=0 and standard deviation=1) using 
the formula: Z=(X-µ)/σ, where µ is the average cell viability obtained for each method, 
X is the specific cell viability for a particular cell passage, and σ is the standard 
deviation for each method. Then, mean z-scores values were obtained for each of the ten 
cell passages analyzed. 
 
Transferase dUTP Nick End Labeling (TUNEL) assay 
Apoptosis of hDPSC was detected by using In Situ Cell Death Detection Kit (Roche 
Diagnostics, Mannheim, Germany) and following the manufacturer’s instructions at 
passages P11, P13, P15, P17 and P19. This fluorescence assay was carried out using 
Chambers slides (LabTek II, Nunc, Rochester, NY, USA). Briefly, 20,000 cells were 
seeded on each well and cultured for 48 h. Then, cells were washed and incubated with 
the TUNEL enzyme and label solution. Finally, the fluorescent reaction was 
counterstained with DAPI and analyzed in a fluorescent microscope. 
Western blot and immunofluorescence 
To obtain whole cell protein extracts, hDPSC were collected in cell lysis buffer 
(Mammalian cell lysis kit, Sigma-Aldrich Ltd, Steinheim, Germany). All samples were 
incubated on ice for 15 min and centrifuged at 10,000 rpm for 5 min. Each protein 
extract was quantified using a Commassie Blue protein assay (Bio-Rad Laboratories, 
Hercules, CA, USA). Equal amounts of protein were loaded onto a 7.5% 
polyacrylamide gel (Mini-PROTEAN© TGX, Bio-Rad Laboratories, Hercules, CA, 
USA) and separated by electrophoresis. Proteins were then transferred to a 
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nitrocellulose membrane using 2.5A current for 3 min. The membrane was blocked in 
blocking buffer (WesternDot©, Invitrogen, Eugene, OR, USA) for 1 hour at room 
temperature and incubated with anti-BCL7C (Abcam, Cambridge, UK), anti-Caspase 4 
(Abcam, Cambridge, UK), anti-PCNA (Sigma-Aldrich, St Louis, MO, USA), anti-
hTERT (Abcam, Cambridge, UK) or anti-β-actin antibodies (Sigma-Aldrich, St Louis, 
MO, USA) at 4ºC overnight. After rinsing in washing buffer (WesternDot©, Invitrogen, 
Eugene, OR, USA), the membrane was incubated with Biotin-XX-goat anti-mouse IgG 
secondary antibody (BCL7C, PCNA and β-actin) (Invitrogen, Eugene, OR, USA) or 
Biotin-XX-goat anti-rabbit IgG secondary antibody (Caspase 4) (Invitrogen, Eugene, 
OR, USA) for 30 min at room temperature. Positive bands were detected using an Qdot 
625 streptavidin fluorescent system (WesternDot©, Invitrogen, Eugene, OR, USA) 
according to the manufacturer’s instructions. 
Immunofluorescence staining of these proteins was performed at P11, P13, P15, P17 
and P19 using chamber slides (LabTek II, Nunc, Rochester, NY, USA). 20,000 cells 
were seeded on each well and cultured for 48 h. Then, cells were rinsed twice with PBS, 
and permeabilized with 0,1% Triton X-100 (Panreac, Barcelona, Spain), after double 
rinse with PBS, hDPSC were blocked with 1% Casein solution (Vector Laboratories 
Inc, Burlingame, CA, USA). Primary antibodies anti-BCL7C, anti-Caspase 4 and anti-
PCNA (the same antibodies used for western blotting) were incubated at 4º C overnight. 
Anti-mouse-FITC and anti-rabbit-Cy3 secondary antibodies (Sigma-Aldrich, St. Louis, 
MO, USA) were incubated for one hour at room temperature and mounted using 
Vectashield with DAPI Vector Laboratories Inc, Burlingame, CA, USA). 
Statistical Analysis 
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For the pairwise comparison of sequential cell passages (i.e., P11 vs. P12, P12 vs. P13, 
etc.) and to detect any differences between two consecutive subcultures, we used the 
Wilcoxon statistical test. To globally compare the 10 cell passages and to identify 
differences among the 10 passages, we used the Friedman’s F test. These statistical tests 
were carried out by using SPSS 15 software (SPSS Inc, Chicago, IL, USA). The 
significance level was set at p < 0.05 for all tests, and all comparisons were performed 
double-tailed. 
 
RESULTS 
Trypan Blue exclusion test 
Trypan blue staining analysis revealed that cell viability was above 75% for all 10 
passages analyzed here. The percentage of live cells showed a significant decreasing 
trend from P11 to P20 (p = 0.009 for the Friedman test) (Figure 1A). The percentage of 
viable cells significantly decreased from P11 to P12 (92.54 ± 7.27% to 87.89 ± 7.14% 
respectively, p = 0.009 for the Wilcoxon test) and from P18 to P19 (91.15 ± 5.77% to 
75.94 ± 23.09%, p = 0.027). The lowest cell viability was found at the end of the study 
(75.50 ± 22.62% for P20) (Tables 1 and 2). 
 
WST-1 assay 
When the WST-1 cell proliferation and metabolism assay was performed, our results 
showed that hDPSC tended to remain stable during all the study (Figure 1B). WST-1 
did not show any statistically significant differences among all the subcultures (p = 
0.853) (Table 2) and no increasing or decreasing behavior of cell viability was identified 
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for the 10 cell passages analyzed in this work. However, a significant increase of cell 
viability was found between P13 and P14 (1.70 ± 0.59% to 2.09 ± 0.29%, p = 0.037) 
(Table 1).  
 
LIVE/DEAD® cell viability assay 
LIVE/DEAD® Viability/Cytotoxicity method showed that cell viability of the analyzed 
hDPSC was always over 90% until P15. Beyond this subculture, cell viability became 
less than 90% and reached the lowest values at P19 (87.67 ± 7.65%) (Table 1). Overall, 
the statistical analysis revealed that cell viability changed (decreasing trend) until the 
last passage (Figure 1C), as revealed by the Friedman test (p = 0.002) (Table 2). 
Statistically significant changes between successive passages were found between P11 
and P12 (90.20 ± 7.63% to 92.67 ± 5.63%, p = 0.031) and from P15 to P16 (91.52 ± 
6.25% to 89.81 ± 4.74%, p = 0.021) (Figure 2). 
 
Electron probe X-ray microanalysis 
As shown in table 3, the intracellular sodium concentration significantly varied among 
different hDPSC subcultures (p < 0.001 for the Friedman test), ranging from 68.02 ± 
35.63 mmol/kg at P11 to 109.06 ± 47.25 mmol/kg at P20, although the differences 
between two consecutive cell passages were not statistically significant (Table 2). 
Magnesium levels tended to decrease during all the experiment. Differences on 
magnesium concentration were detected when all passages were considered globally (p 
< 0.001) (Table 2 and 3). Magnesium concentration showed a significant decrease at 
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P14 (17.97 ± 6.67 mmol/kg, p = 0.006) and increased between P17 and P18 (19.49 ± 
19.84 mmol/kg to 20.62 ± 6.76 mmol/kg, p = 0.010).  
Results regarding phosphorus concentrations revealed a slight decreasing trend during 
all the study, ranging from 221.76 ± 33.90 mmol/kg at P11 to 186.11 ± 33.07 mmol/kg 
at P20 with a significant decrease at P14 (191.23 ± 49.67 mmol/kg, p = 0.011) and P19 
(170.19 ± 39.69 mmol/kg, p = 0.036), and a significant increase at the end of the study 
(186.11 ± 33.07 mmol/kg at P20, p = 0.021). Friedman test also detected a global 
decreasing trend when all passages were considered (p < 0.001) (Table 2). 
Sulfur values ranged from 66.13 ± 16.67 mmol/kg at P12 to 101.22 ± 29.67 mmol/kg at 
P18 with significant changes between subsequent hDPSC subcultures (p < 0.001) 
Although sulfur concentrations oscillated during all the study, a slightly ascending trend 
could be observed. Due to these oscillations between pairs of subcultures, several 
significant differences were obtained: from P11 to P12 (p < 0.001); from P12 to P13 (p 
< 0.001); from P14 to P15 (p = 0.011); from P18 to P19 (p = 0.006); and from P19 to 
P20 (p = 0.035) (Table 2). 
Intracellular chlorine concentration showed a decrease among subsequent passages, 
with significant changes (p < 0.001) from P17 to P18, from P18 to P19 and from P19 to 
P20. Friedman test revealed a global significant reduction among all the hDPSC 
subcultures (p < 0.001). The lowest chlorine concentrations were found at P19 (89.47 ± 
24.43 mmol/kg) (Table 3). 
Similarly, a decreasing trend was found for potassium concentrations, with the 
Friedman statistical test revealing significant changes (p < 0.001) when all passages 
were analyzed globally. Wilcoxon test revealed significant reduction of potassium 
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concentrations from P11 to P12 (p = 0.035); from P12 to P13 (p < 0.001); from P14 to 
P15 (p = 0.022) and from P18 to P19 (p = 0.003) (Table 2 and 3). 
Calcium concentration showed an increasing trend through all cell passages (p = 0.003), 
with several significant differences (p <0.05) between passages P11 and P15 (Table 2). 
 
Analysis of K/Na ratio 
The K/Na ratio is one of the most important microanalytical cell viability markers. 
According to this microanalytical indicator, hDPSC showed a clear loss of cell viability 
as they were passaged from P11 to P20 (p < 0.001 for the Friedman test) (Figure 1D). 
The K/Na ratio decrease was statistically significant from P11 to P12 (5.61 ± 2.56 and 
4.16 ± 2.42 respectively, p = 0.001) from P12 to P13 (p = 0.001) and from P18 to P19, 
when K/Na ratio showed its minimal value (1.81 ± 0.97, p = 0.004) (Tables 2 and 3). 
 
Average Cell Viability Levels (ACVL) 
Based on the results of the previously analyzed assays, ACVL was calculated for each 
cell passage. As shown in Figure 1E, the highest ACVL corresponded to P11, with high 
values also found at P14. As hDPSC were subcultured up to 20th subculture, the ACVL 
tended to gradually diminish until reaching its lowest value (lowest cell viability) at 
P19. 
 
Transferase dUTP nick end labeling (TUNEL) assay 
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The number of apoptotic cells was determined by TUNEL assay in each hDPSC 
subculture (Figure 4). The percentage of apoptotic cells significantly increased from 
P15 to P17 (0.93 ± 0.38% to 7.21 ± 2.07%, p = 0.005) and continued increasing until 
the end of the study, when the top percentage of apoptotic cells was found (9.80 ± 
6.08%), showing a global trend to increase (p < 0.001for Friedman test) (Table 1). 
 
Western blot and immunofluorescence 
Selected apoptosis and proliferation markers were analyzed by western blot and 
immunofluorescence. Caspase 4 expression (pro-apoptotic marker) was slightly higher 
on P16 to P20 as compared to P11 to P15, especially at the end of the experiment (P18 
to P20). Immunofluorescence staining revealed a positive cytoplasmic pattern of 
expression, mainly at P19. BCL7C protein, related with anti-apoptotic activity, also 
presented a cytoplasmic pattern by immunofluorescence and its expression was higher 
during the first five subcultures (P11 to P15), mainly at P14 and P15, as determined by 
western blot and immunofluorescence, and after that, expression decreased to almost 
absence (Figure 3). 
PCNA is a well-known cell proliferation indicator. Its expression was higher at the 
beginning of the study (P11 to P15) and tended to slightly decrease as the hDPSC were 
subcultured (P16 to P20) (Figure 3). Immunofluorescence staining showed a typical 
nuclear pattern of expression mainly at P11, P13 and P15. Finally, telomerase activity 
determined by hTERT expression showed a slight loss of expression at P17 and P19, as 
well as an increase at P15. 
 
DISCUSSION 
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Human dental pulp stem cells (hDPSC) are a promising mesenchymal stem cell 
population that can be obtained autologously from the pulp tissue of human adult teeth, 
especially from young patients subjected to third molar extraction (2). Dental pulp is a 
mucous connective tissue, which is usually catalogued as an embryonic-like tissue (31-
32). hDPSC have been recently proposed as appropriate cells for use in Regenerative 
Medicine and TE applications, including the development of biological substitutes of 
the dental pulp tissue (13-14), cartilage (16) and bone (17-18), tooth development (15), 
bone regeneration (5, 7-8), or cardiac regeneration (19) among others. 
Due to the increasing relevance of hDPSC as cell source in Regenerative Medicine, it is 
important to analyze the functionality and suitability of these cells previously to their 
use in clinical protocols. One important aspect of the quality control that these cells 
should be subjected to is detection of the best cell populations that will ensure optimal 
functionality, cell viability and thus, clinical effectiveness. Therefore, analysis of cell 
viability profiles is an important requirement in the evaluation of hDPSC used in 
therapeutic applications. 
Previous research evaluated cell viability of hDPSC during the first ten passages (23), 
and “Average Cell Viability Levels” (ACVL) were calculated using a combinatorial 
index including four different cell viability assays. Results of this previous paper 
showed that the top cell viability was found in the 9th subculture (P9). However, recent 
studies suggested that the cloning ability of stem cells from dental pulp may be optimal 
after ten passages (33), suggesting that further studies should be carried out. Even more,  
hDPSC have shown to be very resistant cell under culture conditions as they can be  
expanded over the Hayflick's limit (more than 60 populations doublings) preserving 
cytogenetic stability and remaining undifferentiated (34). Nevertheless, no studies had 
been carried out to the date to determine hDPSC cell viability at long-term subcultures 
Page 15 of 39
URL: http://mc.manuscriptcentral.com/cytotherapy  E-mail: cytotherapy@bellsouth.net
Cytotherapy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
(beyond P10). In this study, we evaluated ten subsequent long-term hDPSC subcultures 
(P11 to P20) corresponding to young human teeth in order to shed light on the cell 
viability profiles of hDPSC kept in culture using a comprehensive approach including 
several highly sensitive methods.  
One of the most extensively used cell viability methods is trypan blue dye exclusion 
test. However, it is well-known that this technique is not accurate enough to detect early 
cell damage, but it only identifies cell alterations once they have become irreversible 
and the cell membrane is disrupted (20, 35). In our study, evaluation of cell viability by 
trypan blue exclusion method showed a slightly decreasing trend, especially from P15. 
Interestingly, the percentage of viable cells significantly decreased from P19, suggesting 
that hDPSC should not be used at P19 or P20. Furthermore, the use of LIVE/DEAD® 
dual metabolic/exclusion techniques showed similar profiles. hDPSC were viable up to 
P15 and then, cell viability became significantly reduced, reaching the lowest values at 
the final subcultures (P19 and P20). These findings suggest that cells corresponding to 
P15 to P20 may have certain degree of cell membrane damage associated to metabolic 
impairment at the cytoplasmic level. Surprisingly, passages P10 to P14 showed high 
cell viability, suggesting that these passages could be appropriate for clinical use. 
Moreover, we wanted to evaluate mitochondrial function and cell proliferation using 
WST-1 assays. WST-1 is a metabolic technique that could comp ement other cell 
viability assays, providing specific information about mitochondrial functionality. In 
agreement with the results found for trypan blue and LIVE/DEAD® methods, cells 
corresponding to P11 to P14 showed the most adequate mitochondrial function, thus 
pointing out the possibility of using these cell populations. To further confirm this 
statement, we performed PCNA protein analyses, as well as hTERT expression,  at each 
specific cell passage, and we corroborated that the first passages analyzed in this work 
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(P11 to P15) showed slightly higher proliferation rate than the last 5 passages (P16 to 
P20). Despite this trend, both the WST-1 assay and PCNA detection suggest that the 
proliferation rate of hDPSC is relatively conserved from P11 to P20, and reveals that the 
proliferative capability of these cells is not deeply affected by cell culturing. 
Furthermore, telomerase activity determined by hTERT expression was detectable from 
P11 to P20, confirming the maintenance of cell viability and cell proliferation of 
hDPSC after 20 subcultures. HTERT expression was higher at P15 probably as a 
consequence of a cellular mechanism to prevent senescence. Similar results were seen 
regarding BCL7C anti-apoptotic protein expression. After P15, hTERT activity 
decreased confirming a loss of proliferation, as confirmed by PCNA. This senescence 
stage will also occur at the same time with a loss of cell viability due to an apoptotic 
process. 
On the other hand, EPXMA allows both qualitative and quantitative determination of 
the ionic elements that play a role in cell viability. Mainly, the K/Na ratio is considered 
to be one of the most powerful microanalytical indicators of cell damage, and many 
works have been carried out to accurately determine cell viability in other cell types by 
K/Na ratio quantification (28-29, 36-37). Our EPXMA results found a significant loss 
of cell viability at P12 and P13 subcultures as determined by K/Na ratio. Potassium 
concentrations were significantly reduced at these subcultures and sodium was 
increased when compared with previous passages. Furthermore, chlorine levels 
significantly decreased at P12. Various authors described that the early decrease in K 
and Cl concentrations is a powerful early predictor of pre-apoptosis, reporting that the 
decrease in Cl may be the more important of the two and may be used to predict early 
cell damage (30, 38). In order to confirm this hypothesis in our study, several 
techniques were use to detect apoptosis on cultured cells. 
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Firstly, we used the TUNEL assay to detect cells with DNA fragmentation, i.e. cells in 
established state of apoptosis. Secondly, the expression of two relevant proteins (the 
pro-apoptotic protein caspase 4 and the anti-apoptotic protein BCL7C) was analyzed by 
western blotting. As the obtained results showed, a significant percentage of apoptotic 
cells was found by TUNEL assay at P17, with almost 10% of the cells undergoing 
apoptosis at P19, thus confirming that these later passages could not be adequate for TE 
protocols. In accordance with these results, expression of the pro-apoptotic protein 
caspase 4 was higher from P16 to P20 as compared to P11 to P15, especially at passages 
P18, P19 and P20, when ACVL showed its lowest values. In contrast, the expression of 
the anti-apoptotic marker BCL7C was downregulated from P16 and upregulated at P14 
and P15, when high viability levels were detected and TUNEL assay showed few 
apoptotic cells. As seen, expression of BCL7C was lower as hDPSC were subcultured. 
In agreement, Garzon and cols. (22) reported than some genes of the BCL family 
(BCL2L2) may be involved on complex live-death equilibrium on cultured 
mesenchymal stem cells. 
In summary, hDPSC corresponding to 18-30 years-old donors and cultured in DMEM 
showed high average cell viability levels (ACVL) up to passage P14 and thus, hDPSC 
of 14 passages could be used in regenerative medicine and TE. These cells still maintain 
high functionality and membrane integrity, as well as high proliferation capabilities. 
From P15 to the end of the study, some relevant ionic changes occurred, leading to 
apoptosis and loss of proliferation. Subcultures of hDPSC far from passage 15 should 
be, in consequence, discarded for therapeutical use since they do not fulfill the 
minimum quality control requirements for clinical use. In contrast to the general 
assumption that only the first cell passages should be clinically used, these stem cells 
isolated from a embryonic-like tissue such as the dental pulp are able to maintain 
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adequate cell viability and functionality (cytoplasmic and mitochondrial) until P14. 
These results may lead to a revision of the cell culture protocols that are currently 
accepted. However, these results should be confirmed by independent studies including 
younger and older teeth donors and different culture media. 
 
ACKNOWLEDGEMENTS 
This study was supported by the Spanish Plan Nacional de Investigación Científica, 
Desarrollo e Innovación Tecnológica (I+D+I) from the National Ministry of Science 
and Innovation (Instituto de Salud Carlos III), grants FIS PI11/1582 and PI11/2668. 
Martin-Piedra, MA is a recipient of a fellowship (AP2010-0279) from the Spanish 
Ministry of Education (“Formación de Profesorado Universitario 2010” progamme). 
 
AUTHOR DISCLOSURE STATEMENT 
Authors declare the absence of any commercial association that might create a conflict 
of interest in connection with this manuscript. 
 
REFERENCES 
1. Karaoz E, Demircan PC, Saglam O, Aksoy A, Kaymaz F, Duruksu G. Human 
dental pulp stem cells demonstrate better neural and epithelial stem cell properties than 
bone marrow-derived mesenchymal stem cells. Histochem Cell Biol. 2011;136(4):455-
73. 
Page 19 of 39
URL: http://mc.manuscriptcentral.com/cytotherapy  E-mail: cytotherapy@bellsouth.net
Cytotherapy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
2. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental 
pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 
2000;97(25):13625-30. 
3. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et 
al. Minimal criteria for defining multipotent mesenchymal stromal cells. The 
International Society for Cellular Therapy position statement. Cytotherapy. 
2006;8(4):315-7. 
4. Shi S, Bartold PM, Miura M, Seo BM, Robey PG, Gronthos S. The efficacy of 
mesenchymal stem cells to regenerate and repair dental structures. Orthod Craniofac 
Res. 2005;8(3):191-9. 
5. Graziano A, d'Aquino R, Laino G, Papaccio G. Dental pulp stem cells: a 
promising tool for bone regeneration. Stem Cell Rev. 2008;4(1):21-6. 
6. Gronthos S, Brahim J, Li W, Fisher LW, Cherman N, Boyde A, et al. Stem cell 
properties of human dental pulp stem cells. J Dent Res. 2002;81(8):531-5. 
7. Laino G, d'Aquino R, Graziano A, Lanza V, Carinci F, Naro F, et al. A new 
population of human adult dental pulp stem cells: a useful source of living autologous 
fibrous bone tissue (LAB). J Bone Miner Res. 2005;20(8):1394-402. 
8. Laino G, Graziano A, d'Aquino R, Pirozzi G, Lanza V, Valiante S, et al. An 
approachable human adult stem cell source for hard-tissue engineering. J Cell Physiol. 
2006;206(3):693-701. 
9. Buurma B, Gu K, Rutherford RB. Transplantation of human pulpal and gingival 
fibroblasts attached to synthetic scaffolds. Eur J Oral Sci. 1999;107(4):282-9. 
10. Kuo MY, Lan WH, Lin SK, Tsai KS, Hahn LJ. Collagen gene expression in 
human dental pulp cell cultures. Arch Oral Biol. 1992;37(11):945-52. 
Page 20 of 39
URL: http://mc.manuscriptcentral.com/cytotherapy  E-mail: cytotherapy@bellsouth.net
Cytotherapy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
11. Perry BC, Zhou D, Wu X, Yang FC, Byers MA, Chu TM, et al. Collection, 
cryopreservation, and characterization of human dental pulp-derived mesenchymal stem 
cells for banking and clinical use. Tissue Eng Part C Methods. 2008;14(2):149-56. 
12. Shiba H, Fujita T, Doi N, Nakamura S, Nakanishi K, Takemoto T, et al. 
Differential effects of various growth factors and cytokines on the syntheses of DNA, 
type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in 
cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture. J Cell 
Physiol. 1998;174(2):194-205. 
13. Cavalcanti BN, Zeitlin BD, Nör JE. A hydrogel scaffold that maintains viability 
and supports differentiation of dental pulp stem cells. Dental materials : official 
publication of the Academy of Dental Materials. 2013;29:97-102. 
14. Yu J, Deng Z, Shi J, Zhai H, Nie X, Zhuang H, et al. Differentiation of dental 
pulp stem cells into regular-shaped dentin-pulp complex induced by tooth germ cell 
conditioned medium. Tissue engineering. 2006;12:3097-105. 
15. Xiao L, Tsutsui T. Three-dimensional epithelial and mesenchymal cell co-
cultures form early tooth epithelium invagination-like structures: expression patterns of 
relevant molecules. Journal of cellular biochemistry. 2012;113:1875-85. 
16. Rizk A, Rabie ABM. Human dental pulp stem cells expressing transforming 
growth factor β3 transgene for cartilage-like tissue engineering. Cytotherapy. 2013. 
17. Ito K, Yamada Y, Nakamura S, Ueda M. Osteogenic potential of effective bone 
engineering using dental pulp stem cells, bone marrow stem cells, and periosteal cells 
for osseointegration of dental implants. The International journal of oral & maxillofacial 
implants. 2011;26:947-54. 
18. Seong JM, Kim B-C, Park J-H, Kwon IK, Mantalaris A, Hwang Y-S. Stem cells 
in bone tissue engineering. Biomedical materials (Bristol, England). 2010;5:062001. 
Page 21 of 39
URL: http://mc.manuscriptcentral.com/cytotherapy  E-mail: cytotherapy@bellsouth.net
Cytotherapy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
19. Armiñán A, Gandía C, Bartual M, García-Verdugo JM, Lledó E, Mirabet V, et 
al. Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in 
tissue-specific mesenchymal stem cells. Stem cells and development. 2009;18:907-18. 
20. Alaminos M, Sanchez-Quevedo MC, Munoz-Avila JI, Garcia JM, Crespo PV, 
Gonzalez-Andrades M, et al. Evaluation of the viability of cultured corneal endothelial 
cells by quantitative electron probe X-ray microanalysis. J Cell Physiol. 
2007;211(3):692-8. 
21. Garzon I, Carriel V, Marin-Fernandez AB, Oliveira AC, Garrido-Gomez J, 
Campos A, et al. A combined approach for the assessment of cell viability and cell 
functionality of human fibrochondrocytes for use in tissue engineering. PloS one. 
2012;7(12):e51961. 
22. Garzon I, Perez-Kohler B, Garrido-Gomez J, Carriel V, Nieto-Aguilar R, 
Martin-Piedra MA, et al. Evaluation of the Cell Viability of Human Wharton's Jelly 
Stem Cells for Use in Cell Therapy. Tissue Eng Part C Methods. 2012;18(6):409-19. 
23. Martin-Piedra MA, Garzon I, Oliveira AC, Alfonso-Rodriguez CA, Sanchez-
Quevedo MC, Campos A, et al. Average cell viability levels of human dental pulp stem 
cells: an accurate combinatorial index for quality control in tissue engineering. 
Cytotherapy. 2013;15:507-18. 
24. Rodriguez-Morata A, Garzon I, Alaminos M, Garcia-Honduvilla N, Sanchez-
Quevedo MC, Bujan J, et al. Cell viability and prostacyclin release in cultured human 
umbilical vein endothelial cells. Ann Vasc Surg. 2008;22(3):440-8. 
25. Hoskins JM, Meynell GG, Sanders FK. A comparison of methods for estimating 
the viable count of a suspension of tumour cells. Exp Cell Res. 1956;11(2):297-305. 
26. Phillips HJ. In dye exclusion tests for cell viability. 2nd ed. New York: 
Academic Press; 1973. 
Page 22 of 39
URL: http://mc.manuscriptcentral.com/cytotherapy  E-mail: cytotherapy@bellsouth.net
Cytotherapy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
27. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new 
insights into their cellular reduction. Biotechnol Annu Rev. 2005;11:127-52. 
28. Roomans GM. Application of X-ray microanalysis to the study of cell 
physiology in cells attached to biomaterials. Eur Cell Mater. 2002;3:1-8. 
29. Warley A, Fernandez-Segura E, Lopez-Escamez JA, Campos A. Changes in 
elemental concentrations in K562 target cells after conjugation with human 
lymphocytes studied by X-ray microanalysis. Cell Biol Int. 1994;18(9):915-6. 
30. Zierold K, Hentschel H, Wehner F, Wessing A. Electron probe X-ray 
microanalysis of epithelial cells: aspects of cryofixation. Scanning Microsc Suppl. 
1994;8:117-26; discussion 26-7. 
31. Kierszenbaum AL, Tres LL. Histology and Cell Biology: An Introduction to 
Pathology. Philadelphia: Elsevier Saunders; 2011. 
32. Welsch U, Deller T. Sobotta Lehrbuch Histologie: Urban & Fischer bei Elsev; 
2010. 
33. Kerkis I, Kerkis A, Dozortsev D, Stukart-Parsons GC, Gomes Massironi SM, 
Pereira LV, et al. Isolation and characterization of a population of immature dental pulp 
stem cells expressing OCT-4 and other embryonic stem cell markers. Cells Tissues 
Organs. 2006;184(3-4):105-16. 
34. Suchánek J, Soukup T, Ivancaková R, Karbanová J, Hubková V, Pytlík R, et al. 
Human dental pulp stem cells – Isolation and long term cultivation. Acta Medica 
(Hradec Králové). 2007;50(3):195-201. 
35. Rodriguez IA, Lopez-Gonzalez G, Rodriguez MA, Campos-Sanchez F, 
Alaminos M. Biological evaluation of 2-hydroxyethylmethacrylate (HEMA) toxicity in 
human gingival fibroblasts with histochemical X-ray microanalysis. J Adhes Dent. 
2011;13(4):375-81. 
Page 23 of 39
URL: http://mc.manuscriptcentral.com/cytotherapy  E-mail: cytotherapy@bellsouth.net
Cytotherapy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
36. Roomans GM. Pharmacological treatment of the ion transport defect in cystic 
fibrosis. Expert Opin Investig Drugs. 2001;10(1):1-19. 
37. Salido M, Vilches J, Roomans GM. Changes in elemental concentrations in 
LNCaP cells are associated with a protective effect of neuropeptides on etoposide-
induced apoptosis. Cell Biol Int. 2004;28(5):397-402. 
38. Sanchez-Quevedo MC, Alaminos M, Capitan LM, Moreu G, Garzon I, Crespo 
PV, et al. Histological and histochemical evaluation of human oral mucosa constructs 
developed by tissue engineering. Histol Histopathol. 2007;22(6):631-40. 
 
 
Page 24 of 39
URL: http://mc.manuscriptcentral.com/cytotherapy  E-mail: cytotherapy@bellsouth.net
Cytotherapy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Figure 1. Analysis of cell viability of sequential passages of hDPSC (P11 to P20). (A) 
Trypan blue exclusion test. (B) WST-1 assay. (C) LIVE/DEAD® assay and (D) K/Na 
ratio obtained by EPXMA. Blue lines show cell viability according to each test used, 
and black lines show viability trends. (E) Average cell viability levels (ACVL). 
*Statistically significant changes in comparison with the previous passage. 
 
Figure 2. Images of hDPSC after fluorescence staining with LIVE/DEAD® from P11 to 
P20 (A-J). (K) Human fibroblasts from oral mucosa used as positive controls. (L) 
Human fibroblasts from oral mucosa treated with Triton X-100 used as negative 
controls. Green: cytoplasmic positive-esterase activity (live cells); red: damaged cell 
membrane allows ethidium homodimer to bind to DNA (dead cells). These images are 
representative of 24 assays performed at each hDPSC subculture. 
 
Figure 3. (A-E) Immunofluorescence microphotographies of hDPSC at P11, P13, P15, 
P17 and P19 of PCNA (green signal on nuclei). (F-J) Inmunofluorescence 
microphotographies of hDPSC at P11, P13, P15, P17 and P19 of Caspase 4 
(cytoplasmic orange signal). (K-O) Inmunofluorescence microphotographies of hDPSC 
at P11, P13, P15, P17 and P19 of BCL7C (cytoplasmic green signal) All images were 
counterstained with DAPI (blue nuclei). (P) Analysis of Caspase 4, BCL7C, PCNA, 
hTERT and β-actin expression bywestern Blot, from P11 to P20. 
 
Figure 4. Apoptosis analysis of sequential hDPSC subcultures as determined by 
TUNEL assay. The first 5 panels correspond to fluorescence microphotographies of 
P11, P13, P15, P17 and P19, in which apoptotic cells with fragmented DNA have been 
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labeled in green. The last panel represent the percentage of apoptotic cells per 
subculture. 
 
Table 1. Analysis of cell viability at successive hDPSC passages (P1 to P10) according 
to trypan blue exclusion test, WST-1 assay and LIVE/DEAD® assay. Mean and 
standard deviation (SD) as well as median values and first and third quartiles (Q1-Q3) 
are shown for each passage and technique. 
 
Table 2. Statistical p values for the comparison between each passage and the next one 
using the Wilcoxon test and for the global comparison of the 10 passages analyzed here 
using the Friedman test. Statistically significant differences (p < 0.05) are highlighted in 
bold. 
 
Table 3. Quantification of intracellular ionic concentrations and K/Na ratio in ten 
consecutive hDPSC passages (P11-P20) as determined by electron probe X-ray 
microanalysis (EPXMA). 
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Analysis of cell viability of sequential passages of hDPSC (P11 to P20). (A) Trypan blue exclusion test. (B) 
WST-1 assay. (C) LIVE/DEAD® assay and (D) K/Na ratio obtained by EPXMA. Blue lines show cell viability 
according to each test used, and black lines show viability trends. (E) Average cell viability levels (ACVL). 
*Statistically significant changes in comparison with the previous passage.  
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Images of hDPSC after fluorescence staining with LIVE/DEAD® from P11 to P20 (A-J). (K) Human fibroblasts 
from oral mucosa used as positive controls. (L) Human fibroblasts from oral mucosa treated with Triton X-
100 used as negative controls. Green: cytoplasmic positive-esterase activity (live cells); red: damaged cell 
membrane allows ethidium homodimer to bind to DNA (dead cells). These images are representative of 24 
assays performed at each hDPSC subculture.  
160x159mm (300 x 300 DPI)  
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(A-E) Immunofluorescence microphotographies of hDPSC at P11, P13, P15, P17 and P19 of PCNA (green 
signal on nuclei). (F-J) Inmunofluorescence microphotographies of hDPSC at P11, P13, P15, P17 and P19 of 
Caspase 4 (cytoplasmic orange signal). (K-O) Inmunofluorescence microphotographies of hDPSC at P11, 
P13, P15, P17 and P19 of BCL7C (cytoplasmic green signal) All images were counterstained with DAPI (blue 
nuclei). (P) Analysis of Caspase 4, BCL7C, PCNA, hTERT and β-actin expression bywestern Blot, from P11 to 
P20.  
160x116mm (300 x 300 DPI)  
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Apoptosis analysis of sequential hDPSC subcultures as determined by TUNEL assay. The first 5 panels 
correspond to fluorescence microphotographies of P11, P13, P15, P17 and P19, in which apoptotic cells with 
fragmented DNA have been labeled in green. The last panel represent the percentage of apoptotic cells per 
subculture.  
160x199mm (300 x 300 DPI)  
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CELL PASSAGE P11 P12 P13 P14 P15 P16 P17 P18 P19 P20 
TRYPAN 
BLUE (%) 
Mean ± SD 92.54 ± 7.27 87.89 ± 7.14 89.56 ± 14.47 88.24 ± 8.18 85.61 ± 6.62 85.88 ± 10.68 89.97 ± 7.68 91.15 ± 5.77 75.94 ± 23.09 75.50 ± 22.62 
Median 93.89 87.90 94.99 87.87 85.71 89.09 90.83 92.86 84.03 80.13 
Q1 – Q3 89.38 – 97.83 81.60 – 93.93 79.05 – 100.00 84.49 – 93.45 81.60 – 89.12 81.92 – 92.31 84.29 – 96.43 87.05 – 94.70 71.88 – 90.45 63.35 – 92.73 
WST-1 
(Absorbance) 
Mean ± SD 1.99 ± 0.44 1.58 ± 0.75 1.70 ± 0.63 2.09 ± 0.29 1.93 ± 0.51 1.77 ± 0.59 1.83 ± 0.64 1.89 ± 0.49 1.79 ± 0.71 1.86 ± 0.72 
Median 2.20 1.81 1.48 2.16 2.22 1.91 2.14 2.14 2.13 2.34 
Q1 – Q3 1.58 – 2.34 0.85 – 2.29 1.39 – 2.36 2.14 – 2.23 1.51 – 2.34 1.45 – 2.32 1.48 – 2.36 1.48 – 2.27 1.07 – 2.41 1.05 – 2.38 
LIVE/DEAD 
(%) 
Mean ± SD 90.20 ± 7.63 92.67 ± 5.63 91.81 ± 3.33 92.70 ± 3.41 91.52 ± 6.25 89.81 ± 4.74 91.13 ± 2.94 89.68 ± 9.64 87.67 ± 7.65 89.57 ± 5.69 
Median 91.24 95.17 92.97 92.95 93.60 88.94 91.54 93.73 90.73 91.13 
Q1 – Q3 85.63 – 96.46 88.00 – 97.06 89.32 – 94.17 91.87 – 94.61 85.50 – 96.77 86.07 – 93.49 88.38 – 93.39 84.12 – 96.21 84.90 – 93.41 87.94 – 93.47 
TUNEL (%) 
Mean ± SD 1.46 ± 0.32  2.64 ± 2.09  0.93 ± 0.38  7.21 ± 2.07  9.80 ± 6.08  
Median 1.38  1.86  0.94  6.61  8.51  
Q1 – Q3 1.27 – 1.70  1.45 – 2.65  0.72 – 1.13  6.20 – 7.04  7.44 – 10.31  
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CELL PASSAGES 
P11-
P12 
P12-
P13 
P13-
P14 
P14-
P15 
P15-
P16 
P16-
P17 
P17-
P18 
P18-
P19 
P19-
P20 
ALL 
(Friedman) 
TRYPAN BLUE 0.009 0.796 0.570 0.163 0.877 0.393 0.756 0.027 0.733 0.009 
WST-1 0.090 0.866 0.037 0.848 0.064 0.163 0.509 0.773 0.962 0.853 
LIVE/DEAD 0.031 0.456 0.885 0.848 0.021 0.810 0.773 0.242 0.313 0.002 
EPXMA 
Na 0.063 0.566 0.304 0.337 0.472 0.478 0.540 0.415 0.566 0.000 
Mg 0.114 0.303 0.006 0.969 0.594 0.962 0.010 0.148 0.774 0.000 
P 0.133 0.342 0.011 0.167 0.163 0.067 0.508 0.036 0.021 0.000 
S 0.000 0.000 0.087 0.011 0.406 0.337 0.546 0.006 0.035 0.000 
Cl 0.000 0.206 0.000 0.466 0.866 0.761 0.000 0.000 0.001 0.000 
K 0.035 0.000 0.490 0.022 0.675 0.277 0.211 0.003 0.001 0.000 
Ca 0.001 0.006 0.045 0.003 0.108 0.975 0.598 0.153 0.054 0.003 
 K/Na 0.001 0.001 0.950 0.245 0.237 0.534 0.142 0.004 0.131 0.000 
 P11-P13 P13-P15 P15-P17 P17-P19   
TUNEL 0.074 0.017 0.005 0.139  0.000 
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CELL PASSAGE P11 P12 P13 P14 P15 P16 P17 P18 P19 P20 
Na 
Mean 68.02 81.25 83.75 94.17 105.26 108.34 103.67 99.36 103.11 109.06 
SD 35.63 38.90 36.55 42.35 54.25 44.95 32.49 45.85 37.32 47.25 
Mg 
Mean 24.08 26.06 23.70 17.97 18.52 17.34 19.49 20.62 17.72 17.48 
SD 7.02 7.72 10.92 6.67 8.27 4.04 19.84 6.76 5.35 7.26 
P 
Mean 221.76 209.20 215.07 191.23 174.86 161.60 179.70 188.51 170.19 186.11 
SD 33.90 57.32 49.99 49.67 42.01 41.73 48.43 41.50 39.69 33.07 
S 
Mean 86.06 66.13 87.57 97.63 84.18 88.13 96.44 101.22 83.55 91.51 
SD 17.64 16.67 29.38 31.39 24.11 25.28 30.10 29.67 17.77 17.33 
Cl 
Mean 191.34 147.84 140.82 191.08 198.99 200.74 198.83 143.66 89.47 107.85 
SD 49.25 37.51 74.85 59.93 66.41 51.67 66.13 49.87 24.43 29.04 
K 
Mean 312.81 276.28 205.09 220.37 171.23 167.81 182.04 203.67 161.86 194.37 
SD 86.52 86.57 107.23 110.20 71.87 116.39 81.50 94.00 45.78 53.32 
Ca 
Mean 16.49 9.16 14.26 10.33 17.19 13.96 13.40 15.00 10.71 15.96 
SD 10.14 9.13 9.17 9.15 11.75 9.27 11.94 15.25 9.06 13.92 
K/Na 
Mean 5.61 4.16 3.22 2.95 2.35 2.62 1.98 2.53 1.81 2.19 
SD 2.56 2.42 3.72 2.53 2.18 3.43 1.20 1.80 0.97 1.36 
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Reviewer: 1  
Comments to the Author  
This work has been well carried out. it is a systematic study detailing the progress in viability in cells cultured in 
relatively late passage numbers and the relevance as a source for tissue engineering. The results support the 
conclusions drawn. The literature is well cited.  
Au: We’d like to thank Reviewer 1 for the review and positive comments about this study. 
 
Reviewer: 2  
Comments to the Author  
The analysis of long term culture’s effect on adult stem cells is a challenging issue in stem cell biology. In this 
manuscript, the authors addressed the uncertainty associated with the use of these cells in cell based 
treatments. The study focused on cell viability and proliferation capacity, as well as the alteration of ion 
composition and development of apoptosis in late passages. The study was well designed, and the manuscript 
was reasonably interesting. Some comments were mentioned below:  
Au: We’d like to thank Reviewer 2 for the review and positive comments about this study, as well as 
for suggesting the points needing correction. All queries have been taken into account and the 
revised manuscript has been significantly improved. 
 
-The adult stem cells also show high variability in cell viability respect to the donor age. In this study, the 
number of tissue samples was not adequate (n=4), and the results of cell viability or apoptosis was not 
correlated with the age of tissue donor. It could be very difficult to generalize the results on cell viability and 
proliferation with the limited sample number. It was suggested to increase the tissue number, and correlate at 
least the cell proliferation with the donor age. Thus, the high deviation on these results could be reduced.  
Au: We agree with the reviewer in the possibility to have some differences in cell viability related to 
donor age. That is the reason why we decided to include only dental pulp stem cells (hDPSC) 
corresponding to young adult teeth (from 18 to 30 years old), as stated in page 5, line 17. As the 
reviewer states, it would be very interesting to correlate our results with donor age. However, the aim 
of this study was to determine the optimal subcultures of dental pulp stem cells from young adults 
for their potential use in tissue engineering and we should take into account that the age range used 
in this study is the most common age in which third molars are extracted due to clinical reasons. 
However, since this suggestion is very interesting, we have included it in the discussion section of 
the revised manuscript (Page 19, lines 7-10) and we will take this query into account for further 
research. 
 
-The cell viability was assayed by the kit LIVE/DEAD from Invitrogen. The principle and a short description of 
the method could be given.  
Au: In accordance with reviewer 2, we have added a short description of the principle of the 
LIVE/DEAD kit assay in the revised manuscript version (page 6, line 57 and page 7, lines 3-14)  
-In page 7 line 25, it was described that the sample was plunge-frozen, freeze dried and coated for analysis 
after the culture of cells. A washing step was not mentioned here. Unless there was a washing step for 
components from the culture media, the approach for protection of the cells from contamination or removal of 
contaminants should be described. As the serum is rich in elemental composition and varied drastically from lot 
to lot, there should be an elimination step. The authors should describe the method and mention the 
composition of the fluid used in this step.  
Au: As reviewer 2 gently pointed out, there was a missing washing step when describing the electron 
probe X-ray microanalysis method. Cell were washed in cold deionized water previous to freezing, as 
previously described (Warley, 2001; Alaminos et al., 2007; Garzon et al., 2012). This has been added 
in page 7, line 43-45 on the revised manuscript. 
 
• Warley A. Potassium concentration is reduced in cultured rabbit tracheal smooth muscle 
cells after withdrawal of serum. Cell Biol Int. 2001; 25(7): 691-5. 
• Alaminos M, Sanchez-Quevedo MC, Muñoz-Ávila JI, García JM, Crespo PV, Gonzalez-
Andrades M, Campos A. Evaluation of the viability of cultured corneal endothelial cells by 
quantitative electron probe X-ray microanalysis. J Cell Physiol. 2007; 211(3):692-8. 
• Garzon I, Pérez-Köhler B, Garrido-Gomez J, Carriel V, Nieto-Aguilar R, Martin-Piedra MA, 
Garcia-Honduvilla N, Bujan J, Campos A, Alaminos M. Evaluation of the cell viability of 
human Wharton's jelly stem cells for use in cell therapy. Tissue Eng Part C Methods. 2012; 
18(6):408-19. 
 
 
-The sera used throughout the assay should be same in order to compare the results of different passages. The 
authors might also mention in the method section which serum they used: the supplier, the catalog number and 
the lot number of the serum.  
Au: We also consider fetal bovine serum as an important supplement of the media used in cell 
culture, as reviewer 2 suggests. Fetal bovine serum was supplied by Sigma-Aldrich, Co (Cat. 
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Number: F9665; Lot number: 062M3398, St Louis, MO, USA) in all experiments. This relevant 
information has been included in the revised methods section at page 5, line 43 and 45. 
 
-Western blotting is very reliable method for protein expression, but there are many factors affect the binding 
of the antibody. Hence, this method might be supported with the ELISA. More important point was that the 
staining patterns of the antibodies should be shown by immune staining. The localization of proteins in cells 
could give the specificity of the staining for Caspase4, BCL7C and PCNA.  
Au: Reviewer 2 rightly suggested the need of showing the cellular expression patterns of proteins 
involved in proliferation (PCNA) and apoptosis (BCL7C and Caspase 4). In this sense, as reviewer 2 
suggested, we determined these proteins by immune staining (immunofluorescence) as described in 
page 9, lines 30-51; page 14, lines 20-52 and shown in Figure 3. 
 
hDPSC showed high PCNA expression as a granular nuclear pattern up to P15, which is in agreement 
with our previous western blotting results. Apoptosis-related proteins (Caspase 4 and BCL7C) also 
correlated with results obtained by western blot. Anti-apoptotic protein BCL7C showed cytoplasmic 
expression up to P15, mainly at P14 and P15, when cell retained high viability levels. From P16 to 
P20, expression of BCL7C decreased and cytoplasmic expression of Caspase 4, which induces 
apoptosis, increased. Thus, a resulting loss of viability appeared from P16 to P20 as a consequence 
of lack of expression of BCL7C and PCNA, as well as cytoplasmic expresion of Caspase 4.  
 
Data obtained by new immunofluorescence experiments were included in the revised document: 
matherial & methods, results and discussion, respectively. 
 
-The decrease in cell viability and the increase in apoptotic status were correlated with the increasing passage 
number of the cells. However, the same measurements could also be obtained in the cells with replicative 
senescence. The telomere length might also be evaluated. This is important, because decreased telomere 
length might cause the genetic instability, which might lead the cancer development.  
Au: We would like to thank to reviewer 2 for his/her suggestions in this sense. We agree in the need 
of evaluating telomerase activity as an important assay to assess senescence. For this reason, in the 
revised manuscript we have carried out new experiments no analyze telomerase by western blot at 
P11, P13, P15, P17 and P19 using a human anti-telomerase reverse transcriptase antibody or hTERT 
(Abcam, Cambridge, UK). Results are shown in the main document (page 17, lines 12-27) and in 
figure 3. 
 
This method has been previously used in cell cultures as a reliable technique for determination of 
telomerase activity (Hiyama et al., 2001; Idrissi et al., 2013) 
 
• Hiyama E, Hiyama K, Yokoyama T, Shay J.W. Inmunohistochemical detection of telomerase 
(hTERT) protein in human cancer tissues and a subset of cells in normal tisues. Neoplasia. 
2001; 3(1): 17-26. 
 
• Idrissi ME, Hervieu V, Merle P, Mortreux F, Wattel E. Cause-specific telomere factors 
deregulation in hepatocellular carcinoma. J Exp Clin Cancer Res. 2013; 32(1): 64. 
 
-In Page 15, line 22. It was emphasize that the cell in P19-20 should not be used due to the decreased viability. 
However, the medium used in this study for culture was DMEM, and there are many other media with improved 
composition, like as DMEM:F12 or alpha-MEM. It not clearly known that the cell cultured in the improved media 
would show the same effect on stem cells.  
Au: We agree with reviewer 2 that culture media may play an important role not only in cell viability of 
stemcell typ cells, but also in the proliferative and differentiation capabilities of these cells. 
 
As the reviewer states, there are several culture media with improved composition. However, in this 
work we used DMEM since our previous work, performed on early cell passages, was carried out 
using his culture medium. To determine the long-term viability of this cell type, it is very important to 
use the same culture conditions, including the culture medium. In addition, DMEM has been 
extensively used for culturing hDPSC (Paranjpe et al., 2011; Peng et al., 2011; Kanafi et al., 2013, 
Martin-Piedra et al., 2013). Interestengly, Kanafi et al., 2013 recently demonstrated that the use of 
DMEM resulted in the highest culture efficiency. To confirm the suitability of DMEM culture medium 
on hDPSC, we have now carried out a cell viability study of these cells using DMEM, DMEM + HAM-
F12 and ALPHA-MEM by LIVE/DEAD method. Preliminary results suggest that no significant 
differences can be found among these groups (see below). 
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In any case, we have incorporated the need of studying these cells using different culture media in 
the revised discussion of the manuscript (page 19, lines 7-10) 
 
• Paranjpe A, Smoot T, Zhang H, Johnson JD. Direct contact with mineral trioxide aggregate 
activates and differentiates human dental pulp cells. J Endod. 2011; 37(12): 1691-5. 
• Peng W, Liu W, Zhai W, Jiang L, Li L, Chang J, Zhu Y. Effect of tricalcium silicate on the 
proliferation and odontogenic differentiation of human dental pulp cells. J Endod. 2011; 37(9): 
1240-6. 
• Martin-Piedra MA, Garzon I, Oliveira AC, Alfonso-Rodriguez CA, Sanchez-Quevedo MC, 
Campos A, Alaminos M. Average cell viability levels of human dental pulp stem cells: an 
accurate combinatorial index for quality control in tissue engineering. Cytotherapy. 2013; 
15(4): 507-18. 
• Kanafi MM, Pal R, Gupta PK. Phenotypic and functional comparison of optimum culture 
conditions for upscaling of dental pulp stem cells. Cell Biol Int. 2013; 37(2): 126-36 
 
 
-In Page 15, line 35. Stem cells in P10-14 were suggested to be the appropriate cells for clinical use. The 
authors only consider the single point, i.e. cell viability. However, stem cells should also posses other well-
preserved functions in clinical applications, for example the differentiation capacity or secretion of cytokines for 
immune regulatory.  
Au: As reviewer 2 suggests, it would be necessary to assess the differentiation capabilities of these 
stem cell as differentiation is one of the requirements for a cell population to be considered as 
mesenchymal stem cells. 
 
Thus, we have performed a differentiation assay at P14, as it is the later subculture which is globally 
considered as optimal for use in tissue engineering. Osteogenic differentiation was performed by 
culturing hDPSC with osteogenic differentiation medium consisting of DMEM supplemented with 100 
nM dexamethasone, 10 nM β-glycerophosphate and 50 µM L-ascorbic acid, as previously reported. 
(Bakopoulou et al., 2011; Lee et al., 2012; Martin-Piedra et al, 2013) After 21 days under osteogenic 
conditions, Alyzarin Red staining was used to reveal extracellular calcium aggregates. As it can be 
seen in the figure below, induced hDPSC showed extracellular calcium (red) while control (not 
induced cells) was negative, suggesting that hDPSC retained differentiation capabilities up to P14, as 
reported by Suchánek et al. 2007 
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• Bakopoulou A, Leyhausen G, Volk J, Tsiftsoglou A, Garefis P, Koidis P, et al. Comparative 
analysis of in vitro osteo/odontogenic differentiation potential of human dental pulp stem 
cells (DPSCs) and stem cells from the apical papilla (SCAP). Arch Oral Biol. 2011; 56(7): 709-
21. 
 
• Lee SY, Kim SY, Park SH, Kim JJ, Jang JH, Kim EC. Effects of recombinant dentin sialoprotein 
in dental pulp cells. J Dent Res. 2012; 91(4): 407-12. 
 
• Martin-Piedra MA, Garzon I, Oliveira AC, Alfonso-Rodriguez CA, Sanchez-Quevedo MC, 
Campos A, Alaminos M. Average cell viability levels of human dental pulp stem cells: an 
accurate combinatorial index for quality control in tissue engineering. Cytotherapy. 2013; 
15(4): 507-18. 
 
• Suchánek J, Soukup T, Ivancaková R, Karbanová J, Hubková V, Pytlík R, et al. Human dental 
pulp stem cells--isolation and long term cultivation. Acta Medica (Hradec Kralove). 2007; 
50(3): 195-201. 
 
-The graphical presentations of the results mentioned in Table 1, 2 and 3 were given. These results could be 
given as supplementary data.  
Au: Following the reviewer's recommendations, these tables will be presented as supplementary 
data. 
 
 
Reviewer: 3  
Comments to the Author  
Manuscript ID CYTH-2013-0116  
"Cell viability and proliferation capability of long-term human dental pulp stem cell cultures for use in tissue 
engineering."  
 
The authors tried to assess the viability and proliferation potentials of hDPSCs for long term passages (more 
than 10 passages as they defined).  
 
Major Comments:  
-The isolation and characterization of the pulp cells is not mentioned with only reference to the first paper by 
Gronthos where isolation and selection of was done by colony forming unit selection. Isolation and 
characterization has largely developed using magnetic bead selection for example to ensure homogeneity of the 
highly variable population of the pulp.  
Au: We’d like to thank Reviewer 3 for the review and positive comments about this study, as well as 
for suggesting the points needing correction. The cell isolation method used in this study was 
initially described by Gronthos et al., 2000. We decided to follow this protocol as it is one of the most 
reported protocols for cell isolation (Gronthos et al., 2002; Shi and Gronthos, 2003; Arthur et al., 
2008), providing homogeneous and clonogenic stem cell populations (Huang et al., 2006). 
 
In addition, the objective of this study was to analyze cell viability of hDPSC at long-term 
subcultures, as we previously showed that cell viability was high up to P10 (Martin-Piedra et al., 
2013). Thus, we decided to evaluate the same cell type using the same isolation and culture 
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conditions, including the isolation method for the following 10 subcultures. 
 
• Gronthos S, Brahim J, Li W, Fisher LW, Cherman N, Boyde A, DenBesten P, Robey PG, Shi S. 
Stem cell properties of human dental pulp stem cells. J Dent Res. 2002; 81(8):531-5. 
• Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone 
marrow and dental pulp. J Bone Miner Res. 2003; 18: 696-704. 
• Arthur A, Rychkov G, Shi S, Koblar SA, Gronthos S. Adult human dental pulp stem cells 
differentiate toward functionally active neurons under appropriate environmental cues. Stem 
Cells.2008; 26(7): 1787-95. 
• Huang GT, Sonoyama W, Chen J, Park SH. In vitro characterization of human dental pulp 
cells: various isolation methods and culturing environments. Cell Tissue Res. 2006; 324(2): 
225-36. 
• Martin-Piedra MA, Garzon I, Oliveira AC, Alfonso-Rodriguez CA, Sanchez-Quevedo MC, 
Campos A, Alaminos M. Average cell viability levels of human dental pulp stem cells: an 
accurate combinatorial index for quality control in tissue engineering. Cytotherapy. 2013; 
15(4): 507-18. 
 
-The authors did not clarify if the 4 samples used were pooled together or treated as independent samples.  
If the samples were treated as individual samples results should be presented individually to see variability 
between samples. If samples were pooled and with donor age ranging between 18 and 30 years, care should be 
taken to reported differences in proliferation and differentiation potentials of teeth with open apex and fully 
formed teeth, specially that only four samples were used.  
Au: Young adult teeth included in this study were always at a fully developed root stage, i.e. teeth 
had closed apex in all cases . Freshly extracted open apex teeth were discarded for this purpose. In 
order to be more specific, we have added this information to the revised manuscript text (page 5, 
lines 22 and 24). 
 
In this work, each individual tooth was treated individually and independent cell cultures and assays 
were performed for each case. However, results were collected for statistical analysis. In short, for 
each method, the four cell cultures were analyzed using 4-6 technical replicates for each culture. 
 
Regarding the age of the donors, we agree in the importance of this parameter. However, the age-
range used was very homogeneous (18-30 years old). As this is a relevant parameter, the importance 
of carrying out specific age-related studies has been incorporated in the revised manuscript (page 
19, lines 7-10). 
 
Results:  
I believe the tables are confusing, specially table 1 which is already presented in figure 1, and better be added 
only to the supplementary materials section.  
Au: As reviewer 3 suggests, table 1, 2 and 3 will be presented as supplementary data. 
 
Figure 2: Figures are not labeled with scale bars except for the first figure, and the captures seems to be taken 
at various magnifications which can be misleading.  
Au: We have carefully revised all figures including microphotographies and we have confirmed that 
all images included on each figure  have been taken at the same magnification. Therefore, the scale 
bar shown in the first image is valid for all images in the figure. 
 
Figure 3: The labeling of figure 3 seems not right as it states under the figure: "(A) Analysis of cell apoptosis by 
transferase dUTPnick end labeling (TUNEL) assay. Green: Cells undergoing DNA fragmentation (apoptotic cells). 
Blue: Cell nuclei of with adequate DNA integrity (live cells)." and the figure 3A only shows statistical analysis. I 
believe the authors mixed the labels with figure 4.  
Au: We apologize reviewer 3 about the mistake and we appreciate the observation. In this sense, we 
would like to inform that we have significantly changed the distribution of our images in new figures 
in order to present results in a more comprehensive approach and figure labeling has been revised. 
 
Figure 4: are the figures labeled correctly ? it seems that B & D are mixed for C & E as denoted from DAPI 
stained nuclei denoting the cells' nuclei of with adequate DNA integrity (live cells), which seems to be increased 
not decreased from A to E.  
Au: The figure and the figure legend have been revised and rewritten for clarity. 
 
Discussion:  
The Authors did not discuss or bring to attention papers performing prolonged subcultures of DPSCs as the 
work of Suchánek et al "HUMAN DENTAL PULP STEM CELLS – ISOLATION AND LONG TERM CULTIVATION".  
Au: This paper has been included in the discussion of our main document, as can be seen in page 
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15, lines 51-56. Moreover, we consider that results published at Suchánek et al., 2007 are very 
relevant in the context of human dental pulp stem cells research, as they confirm the high durability 
and cytogenetic stability of these cells in long term cultivation conditions. 
 
Minor comments:  
There are some mistakes and typos as for example in the Abstract p2 line 42-43, i believe the authors wanted 
to say P11 to P14 not P1.  
Au: We would like to sorry about mistakes included in the abstract of the main document. These 
mistakes have been corrected to promote a better understanding of our research and experiments. 
 
Title seems misleading : "Cell viability and proliferation capability of long- term human dental pulp stem cell 
cultures for use in tissue engineering" while the authors did not assess any differentiation capabilities or tissue 
engineering techniques for DPSCs in their papers. 
Au: Title of the revised manuscript has been modified has suggested. 
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